Current Fellows in the Radiation Epidemiology Branch

Meet the fellows in th Radiation Epidemiology Branch (REB) and learn about their work.
Fellows in the Radiation Epidemiology Branch
-
Macy E. Corley, B.S.N., R.N.
Ms. Corley is validating cancer treatment in SEER using electronic medical record and prescription file data from the Kaiser Permanente Breast Cancer Survivors Cohort.
-
Belinda Gorsuch, B.A.
Ms. Gorsuch studies UV radiation and occupational exposure to radiation and their associations with cancers.
-
Caroline Esposito, B.A.
Ms. Esposito studies pediatric organ dose reconstructions using Monte Carlo simulations.
-
Keith Griffin, Ph.D., M.S.
Dr. Griffin is helping to establish the computational dosimetry methods needed for future epidemiological studies on the use of radiation in medical procedures.
-
Haegin Han, Ph.D.
Dr. Han conducts dose assessment for patients and medical staff during the procedures that involve radiography and fluoroscopy.
-
Tae-Eun Kwon, Ph.D.
Dr. Kwon works on dose assessment for thyroid cancer patients and on dose recalculation for the U.S. Radiologic Technologists Cohort study.
-
Jim Mai, M.D., M.P.H., Ph.D.
Dr. Mai studies UVR exposure, photosensitizing medications, oncoviruses infection/activation, and cancer risk among SEER participants, U.S. radiologic technologists, and Medicare recipients.
-
Sergio Morato Rafet, Ph.D.
Dr. Morato Rafet contributes to projects focusing on Monte Carlo simulations and Deterministic Transport codes to calculate organ dose.
-
Sander Roberti, Ph.D.
Dr. Roberti investigates statistical methods as applied to studies of radiation, in particular related to the Chornobyl nuclear reactor accident.
-
Rienna G. Russo, M.H.S.
Ms. Russo investigates use of statins for cardiovascular disease prevention among breast cancer survivors.
-
Isabelle van der Velpen, M.D., Ph.D.
Dr. van der Velpen studies neurodevelopmental and neurodegenerative outcomes after radiation exposure.
-
Yuehan Wang, Ph.D., M.Sc.
Dr. Wang characterizes the joint effects of radiation dose, chemotherapy, and other risk factors on subsequent thyroid cancer.